Influence of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor on anti-hepatoma activities of human dendritic cells

World Journal of Gastroenterology

Volumn 6, Issue 5, 2000, Pages 718-720

  Zhang, J K ^a   Sun, J L ^a   Chen, H B ^a   Zeng, Y ^a   Qu, Y J ^a  

^a SHANTOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; LYMPHOKINE ACTIVATED KILLER CELL; MONONUCLEAR CELL; PROTEIN ANALYSIS;

EID: 0033786635     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v6.i5.718     Document Type: Article

References (32)

1. Dendritic cells hold promise for immunotherapy
2. Dendritic cells and the control of immunity
3. Dendritic cells
4. Relationship between infiltration of dendritic cells, pericancerous lymphocytic reaction and prognosis in colorectal carcinomas
5. Expression of B7 costimulation molecules by colorectal cancer cells reduces tumorigenicity and induces anti-tumor immunity
6. Effect of dendritic cells on LPAK cells induced at different times in killing hepatoma cells
7. Promoting effects of dendritic cells on LPAK cells killing human hepatoma cells
8. Effects of cytokines on dendritic cells against human hepatoma cell line
9. Separating method of dendritic cells
10. Induction of LAK cells and detection of their activity. The basis of LAK cells and their clinic antitumor application. The first edition
11. Dendritic cells in vitro induce efficient and special anti-tumor immune response
12. Immune response induced by dendritic cells induce apoptosis and inhibit proliferation of tumor cells
13. Study of the phenotype of PBLs activated by CD28/ CD80 and CD2/ CD58 and acting with hepatoma cells and the restricted usage of TCR Vβ gene subfamily
14. CD54, CD80, CD86 and HLA-ABC expressions in liver cirrhosis and hepatocarcinoma
15. Phenotype analysis and restricted usage of TCR Vβ genes subfamily in mAb-costimulated T cells after incubated with hepatocellular carcinoma cell line
16. Advances in clinical research of hepatocellular carcinoma in China
17. 3 McAb
18. Ultrastructural comparison of apoptosis of human hepatoma cells and LAK cells
19. The hematopoietic development of dendritic cells: A distinct pathway for myeloid differentiation
20. Dendritic cells: A major story unfolds
21. Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development
22. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells
23. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response
24. Effect of embryo hepatic extracts on proliferation and differentiation of hepatoma BEL-7402 cells
25. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte - macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-α for use in cancer immunotherapy
26. New insights into the mobilization and phagocytic activity of dendritic cells
27. Lovo cell line apoptosis induced by cycloheximide combined with TNFα
28. Effect of delayed rapid fluid resuscitation on liver function in early stage postburn
29. Biological significance of serum soluble tumor necrosis factor receptor I in hepatoma patients
30. TNF-α induced apoptosis and necrosis of mice hepatocytes
31. Detection of serum TNF-α, IFN-γ, IL-6 and IL-8 in patients with hepatitis B
32. Progress in surgical treatment of primary hepatocellular carcinoma